Pharmacy HOME
Welcome to the Pharmacy Homepage
The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.
The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.
Program Information
- Program/Board Members
Dmitry Kunin, Senior Program Director
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7692 | Email: dora_pharmacyboard@state.co.us
Board Members:
- Kristen Wolf, PharmD, BCSCP, President
Term Expires: July 1, 2027 - Ryan Leyland, PharmD, RPh, Vice President
Term Expires: July 1, 2027 - Patricia A.Evacko, PharmD.
Term Expires: July 1, 2026 - Avani Soni, Pharm.D., RPh
Term Expires: July 1, 2025 - Michael Scruggs, Pharm.D
Term Expires: July 1, 2025 - Alexandra Zuccarelli, MBA
Term Expires: July 1, 2027 - Jayant Patel
Term Expires: July 1, 2027
- Kristen Wolf, PharmD, BCSCP, President
- Public Notices
Colorado Board of Pharmacy – Stakeholder Meeting – July 31,2025
The purpose of this Stakeholder Meeting is for the Board to receive feedback on proposed revisions to 3.00.00 – DISPENSING, 5.00.00 – OUTLETS, 8.00.00 – ADVERTISING, 11.00.00 – RECORD AND RECORDKEEPING, 15.00.00 – WHOLESALERS. The purpose is to implement SB25-289 (CONCERNING THE CREATION OF A DRUG DONATION PROGRAM) and HB25-1222 (CONCERNING MEASURES TO PRESERVE HEALTH-CARE ACCESS PROVIDED BY RURAL INDEPENDENT PHARMACIES). Additionally, proposed revisions to Rule 32.00.00 – CONCERNING HEALTH CARE PROVIDER DISCLOSURES TO CONSUMERS ABOUT THE POTENTIAL EFFECTS OF RECEIVING EMERGENCY OR NONEMERGENCY SERVICES FROM AN OUT-OF-NETWORK PROVIDER and APPENDIX F – YOUR RIGHTS AND PROTECTIONS AGAINST SURPRISE MEDICAL BILLS. The purpose of the proposed rules is to establish requirements for health-care providers to disclose to covered persons who are utilizing a health benefit plan about the potential of “balance billing” when receiving 1) post-stabilization services or 2) covered non-emergency services from an out-of-network provider at an in-network facility.
- Thursday, July 31, 2025, at 9:00 A.M. (MDT)
- Stakeholder Meeting Notice
- Draft Rules
- SB25-289
- HB24-1045
- Webinar Registration
- Submit written comments
- View written comments
- Legislative Updates
- 2025 New Legislation
- HB 25-1270: Patient’s Right to Try Individual Treatments
- HB 25-1087: Confidentiality Requirements for Mental Health Support
- HB 25-1176: Behavioral Health Treatment Stigma for Providers
- HB 25-1222: Preserving Access to Rural Pharmacies
- HB 25-1309: Protect Access to Gender Affirming Care
- SB 25-084: Medicaid Access to Parenteral Nutrition
- SB 25-152: Health-Care Practitioner Identification Requirements
- SB 25-129: Legally Protected Health Care Activity Protections
- SB 25-289: Creation of a Drug Donation Program
- SB 25-1316: Changes to Definition of Monitoring Prescription Drugs
- 2024 New Legislation
- HB 24-1004: Ex-Offenders Practice in Regulated Occupations
- HB 24-1097: Military Family Occupational Credentialing
- HB 24-1342: Test Accommodations for Persons with Disabilities
- SB 24-129: Non Profit Information Sharing
- SB 24-141: Out of State Telehealth Providers
- HB 24-1045: Treatment for Substance Use Disorders
- SB 24-047: Prevention of Substance Use Disorders
- HB 24-1003: Opiate Antagonists and Detection
Products in Schools - HB 24-1037: Substance Use Disorders Harm Reduction
- HB 24-1115: Prescription Drug Label Accessibility
- HB 24-1438: Implement Prescription Drug Affordability Programs
- HB 24-1450: Revisor’s Bill
- SB 24-209: Pharmacy Practice Act
- 2025 New Legislation
- Meeting Minutes
Board Meeting Minutes
- May 8, 2025, Pharmacy Board Meeting Minutes
- March 13, 2025, Pharmacy Board Meeting Minutes
- January 16, 2025, Pharmacy Board Meeting Minutes
Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes